. 2014 Sep 20;24(5):591–602. doi: 10.1007/s00787-014-0613-0

Table 2.

Post-treatment Group-specific mean and response rates

	Estimated mean or rate (95 % CI)^a		Effect sizes CBT vs. SRT (95 % CI)^{b, c}
	Continued CBT	Sertraline	Effect sizes CBT vs. SRT (95 % CI)^{b, c}
Primary outcomes
CY-BOCS total score^d	13.64 (10.96–16.32)	11.65 (7.88–15.42)	−0.29 (−0.85 to −0.27)
CY-BOCS <16^e	0.50 (0.33–0.67)	0.45 (0.27–0.65)	0.10 (−0.72 to 0.52)
Secondary outcomes
COIS-R parent report^f	17.20 (11.74–22.67)	15.50 (8.86–22.14)	−0.11 (−0.67 to 0.45)
COIS-R child report^f	15.39 (11.05–19.73)	8.44 (2.72–14.17)	−0.55 (−1.12 to −0.02)
CY-BOCS <11^g	0.32 (0.18–0.51)	0.27 (0.13–0.48)	−0.22 (−0.41 to 0.85)
30 % reduction^h	0.36 (0.21–0.54)	0.45 (0.27–0.65)	0.13 (−0.81 to 0.55)

^aFor CY-BOCS total score and COIS-R estimated mean score at week 30 from the fitted multilevel model. For the responder status, the estimated rate of response at week 30

^bFor CY-BOCS total score and COIS-R, between-groups difference in estimated mean score at session 30. For the responder status, between-groups difference in rate at week 30

^cNegative effect size suggests that SRT was more effective and positive effect size suggests that continued CBT was more effective

^dCY-BOCS total score range from 0 to 40 with larger scores reflecting more OCD symptoms

^eCY-BOCS <16 reflects participants that obtained CY-BOCS total score of 15 or below at week 30

^fCOIS-R total score range from 0 to 99 with larger scores reflecting more OCD-related functional

^g CY-BOCS < 11 reflects participants that obtained CY-BOCS total score of 10 or below at week 30

^h30 % reduction of CY-BOCS total score from week 13 to week 30